BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17915218)

  • 1. VEGF modulation of retinal pigment epithelium resistance.
    Ablonczy Z; Crosson CE
    Exp Eye Res; 2007 Dec; 85(6):762-71. PubMed ID: 17915218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells.
    Kannan R; Zhang N; Sreekumar PG; Spee CK; Rodriguez A; Barron E; Hinton DR
    Mol Vis; 2006 Dec; 12():1649-59. PubMed ID: 17200665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF receptor 2 inhibitor nintedanib completely reverts VEGF-A
    Deissler HL; Stutzer JN; Lang GK; Grisanti S; Lang GE; Ranjbar M
    Exp Eye Res; 2020 May; 194():108004. PubMed ID: 32184103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of barrier properties and inducible VEGF expression of several types of retinal pigment epithelium in medium-term culture.
    Geisen P; McColm JR; King BM; Hartnett ME
    Curr Eye Res; 2006 Sep; 31(9):739-48. PubMed ID: 16966147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF but not PlGF disturbs the barrier of retinal endothelial cells.
    Deissler HL; Deissler H; Lang GK; Lang GE
    Exp Eye Res; 2013 Oct; 115():162-71. PubMed ID: 23891860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy.
    Miyamoto N; de Kozak Y; Jeanny JC; Glotin A; Mascarelli F; Massin P; BenEzra D; Behar-Cohen F
    Diabetologia; 2007 Feb; 50(2):461-70. PubMed ID: 17187248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal effects of VEGF and anti-VEGF drugs on the permeability or selectivity of RPE tight junctions.
    Peng S; Adelman RA; Rizzolo LJ
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3216-25. PubMed ID: 20042644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human retinal pigment epithelium cells as functional models for the RPE in vivo.
    Ablonczy Z; Dahrouj M; Tang PH; Liu Y; Sambamurti K; Marmorstein AD; Crosson CE
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8614-20. PubMed ID: 21960553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal and apical regulation of VEGF-A and placenta growth factor in the RPE/choroid and primary RPE.
    Klettner A; Kaya L; Flach J; Lassen J; Treumer F; Roider J
    Mol Vis; 2015; 21():736-48. PubMed ID: 26167115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Platelet-Activating Factor on Barrier Function of ARPE-19 Cells.
    Zhang F; Liu L; Zhang H; Liu ZL
    Drug Des Devel Ther; 2020; 14():4205-4214. PubMed ID: 33116408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGF-dependent mechanism.
    Hartnett ME; Lappas A; Darland D; McColm JR; Lovejoy S; D'Amore PA
    Exp Eye Res; 2003 Nov; 77(5):593-9. PubMed ID: 14550401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through gamma-secretase.
    Ablonczy Z; Prakasam A; Fant J; Fauq A; Crosson C; Sambamurti K
    J Biol Chem; 2009 Oct; 284(44):30177-86. PubMed ID: 19723623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Single Routes of Intracellular Signaling is Not Sufficient to Neutralize the Biphasic Disturbance of a Retinal Endothelial Cell Barrier Induced by VEGF-A165.
    Deissler HL; Lang GK; Lang GE
    Cell Physiol Biochem; 2017; 42(4):1493-1513. PubMed ID: 28719888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-α disrupts morphologic and functional barrier properties of polarized retinal pigment epithelium.
    Shirasawa M; Sonoda S; Terasaki H; Arimura N; Otsuka H; Yamashita T; Uchino E; Hisatomi T; Ishibashi T; Sakamoto T
    Exp Eye Res; 2013 May; 110():59-69. PubMed ID: 23454586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PlGF-1 and VEGFR-1 pathway regulation of the external epithelial hemato-ocular barrier. A model for retinal edema.
    Miyamoto N; de Kozak Y; Normand N; Courtois Y; Jeanny JC; Benezra D; Behar-Cohen F
    Ophthalmic Res; 2008; 40(3-4):203-7. PubMed ID: 18421240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cytokines and nitric oxide on tight junctions in cultured rat retinal pigment epithelium.
    Zech JC; Pouvreau I; Cotinet A; Goureau O; Le Varlet B; de Kozak Y
    Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1600-8. PubMed ID: 9699549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Effects of Thrombin on VEGF Secretion, Proliferation, and Permeability in Polarized and Non-polarized Retinal Pigment Epithelial Cells.
    Terasaki H; Shirasawa M; Otsuka H; Yamashita T; Uchino E; Hisatomi T; Sonoda S; Sakamoto T
    Curr Eye Res; 2015 Sep; 40(9):936-45. PubMed ID: 25310246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor mediated disruption of retinal pigment epithelium function in acute glycated-albumin exposure.
    Dahrouj M; Desjardins DM; Liu Y; Crosson CE; Ablonczy Z
    Exp Eye Res; 2015 Aug; 137():50-6. PubMed ID: 26070987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-Time Monitoring the Effect of Cytopathic Hypoxia on Retinal Pigment Epithelial Barrier Functionality Using Electric Cell-Substrate Impedance Sensing (ECIS) Biosensor Technology.
    Guerra MH; Yumnamcha T; Ebrahim AS; Berger EA; Singh LP; Ibrahim AS
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties.
    Dunn KC; Aotaki-Keen AE; Putkey FR; Hjelmeland LM
    Exp Eye Res; 1996 Feb; 62(2):155-69. PubMed ID: 8698076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.